Ketamine Therapy for Depression, Anxiety, and Trauma

Exploring how Ketamine-Assisted Therapy (KAP) can support relief and healing for people living with depression, anxiety, PTSD and treatment-resistant conditions.

Healing is possible—even when it feels distant or out of reach. For individuals living with depression, anxiety, trauma, or emotional patterns that have felt immovable, ketamine therapy and ketamine-assisted therapy (KAP) can offer a scientifically grounded, clinically supervised path toward relief.

At Emergence Psychedelic Therapy in Boulder, Colorado, ketamine treatment is delivered within a physician-led, therapeutic framework designed to support safety, emotional processing, and meaningful long-term healing.

What Is Ketamine? 

Ketamine is a medication that has been used safely in medical and surgical settings for more than 50 years. It is FDA-approved as an anesthetic; its use at lower, sub-anesthetic doses for depression, anxiety, PTSD, and related conditions is considered off-label, but is supported by a substantial and growing body of clinical research.

At these therapeutic doses, ketamine works through a mechanism different from standard antidepressants. Rather than acting primarily on serotonin or dopamine, ketamine influences the brain’s glutamate system, one of the most important chemical pathways involved in learning, memory, and neural adaptability. By blocking NMDA receptors and enhancing AMPA signaling, ketamine appears to increase levels of BDNF (a growth factor in the brain), promote synaptogenesis (the creation of new neural connections), and strengthen neuroplasticity—the brain’s ability to reorganize and form new patterns.

These effects may help interrupt entrenched cycles of negative thinking, reduce rumination, and create a window in which emotional and cognitive change becomes more accessible.

Put simply: ketamine helps the brain “unstick” old patterns so people can experience relief from overwhelming thoughts and feelings, and begin to feel more open, flexible, and hopeful again.

The Science Behind Ketamine Therapy

Over the past two decades, research has shown that ketamine can produce rapid antidepressant effects, including in individuals with major depressive disorder (MDD) who have not responded to other treatments. Randomized controlled trials and meta-analyses demonstrate that low-dose ketamine can significantly reduce depressive symptoms within hours to days in many people with treatment-resistant depression (TRD).

There is also growing evidence that ketamine may help people with post-traumatic stress disorder (PTSD). A landmark randomized, double-blind, crossover trial in chronic PTSD found that intravenous ketamine produced rapid symptom reductions, and newer studies suggest repeated dosing may further decrease PTSD symptoms.

Multiple clinical trials have evaluated ketamine’s effects on suicidal ideation, with several showing that adjunctive ketamine can reduce suicidal thoughts within 24 hours. Systematic reviews support ketamine’s potential to rapidly lessen suicidal thinking in some individuals, at least over the short term.

Research into ketamine for generalized anxiety, bipolar depression, and other conditions is promising but still developing. Some studies suggest benefit, but these indications require careful medical assessment and remain under active investigation.

Use of Ketamine for Psychiatric Indications

Ketamine can be administered in several forms—including intravenous (IV), intramuscular (IM), and oral lozenges—and its use for conditions such as depression, anxiety, and PTSD is considered off-label. Off-label use simply means that these specific formulations and routes of administration have not yet gone through the FDA approval process for psychiatric indications, even though they are supported by a growing body of clinical research and used safely in many physician-led practices across the country.

When provided within a medically supervised environment—with thorough screening, individualized dosing, careful monitoring, and structured follow-up—ketamine can be a safe, effective, and well-tolerated option for many people seeking relief from mood and trauma-related symptoms. Receiving treatment in a physician-guided setting offers a more comprehensive level of care, ensuring coordination, attentive oversight, and an approach designed to reduce risk while enhancing therapeutic benefit.

Esketamine (Spravato)

In 2019, the FDA approved esketamine (Spravato)—a ketamine derivative delivered as a nasal spray—for adults with treatment-resistant depression, initially in conjunction with an oral antidepressant. In 2025, this approval expanded to allow its use as monotherapy for certain adults with major depressive disorder. Standard IV, IM, and oral ketamine used in medical clinics remain off-label for psychiatric use, though widely implemented and studied.

Ketamine-Assisted Psychotherapy (KAP)

An additional area of research is ketamine-assisted psychotherapy (KAP), which involves combining ketamine administration with structured therapeutic support. Early reviews suggest that psychotherapy before and after ketamine sessions may help extend and deepen benefits by leveraging ketamine’s neurobiological and psychological effects, though high-quality randomized trials are still emerging.

Overall, scientific literature supports ketamine as a rapid-acting intervention for certain mood and trauma-related conditions when delivered with appropriate evaluation, monitoring, integration, and medical oversight.

Ketamine Therapy Compared to Traditional Antidepressants

Traditional antidepressants target monoamine systems and often require weeks for full effect. Ketamine acts primarily through glutamatergic pathways and may produce noticeable effects within hours or days.

Rather than masking symptoms, ketamine can create a neurobiological environment that supports deeper emotional processing and behavioral change—especially when paired with therapy. This is the foundation of ketamine-assisted psychotherapy.

What Ketamine Therapy Can Feel Like

While each person’s experience is unique, many report:

  • Emotional softening
  • Relief from rumination or negative cycles
  • Reduced anxiety
  • A sense of spaciousness or perspective
  • Increased self-compassion
  • Renewed capacity for insight or clarity

Some individuals experience gentle visual imagery or feelings of floating; others experience stillness, quiet, or introspection. All experiences are held with care.

Who May Be a Candidate for Ketamine-Assisted Therapy?

Ketamine therapy may be considered for adults who:

  • Have not found adequate relief from standard treatments
  • Experience chronic or treatment-resistant depression
  • Live with trauma-related symptoms or PTSD
  • Feel emotionally “stuck,” numb, or disconnected
  • Wish to deepen therapeutic work in a supported, supervised setting

Suitability depends on medical and psychiatric evaluation, not on diagnosis alone.

Potential Benefits of Ketamine Therapy

When integrated thoughtfully, ketamine therapy may offer:

  • Rapid reductions in depressive symptoms
  • Decreased suicidal ideation
  • Relief from trauma-related symptoms
  • Greater emotional flexibility
  • Enhanced engagement in psychotherapy
  • Renewed motivation and sense of possibility

Many clients describe ketamine-assisted therapy as a “reset” or opening—a shift that allows them to approach healing from a different vantage point.

Safety and Medical Oversight

Ketamine can be a safe and effective therapeutic tool when delivered in a controlled medical environment with appropriate screening, monitoring, and follow-up. At Emergence Psychedelic Therapy, treatment is provided within a physician-led model designed to identify risks early, ensure medical stability, and support clients throughout the entire course of care.

Why Screening Matters

A thorough medical and psychiatric evaluation ensures that ketamine is appropriate, safe, and clinically indicated. Screening includes medical history, psychiatric history, medication review, substance use patterns, and ability to participate in preparation and integration work.

Medical Contraindications and Precautions 

Certain medical conditions may make ketamine inappropriate or require additional precautions, including:

  • Uncontrolled hypertension or significant cardiovascular disease
  • History of stroke or aneurysm
  • Increased intracranial pressure
  • Severe liver disease
  • Pregnancy or breastfeeding
  • Significant respiratory compromise
  • Active intoxication or allergy to ketamine

Vital signs and medical stability are monitored during every session.

Psychiatric Contraindications and Red Flags

Some psychiatric presentations require caution or alternate care pathways, such as:

  • Active psychosis
  • Current manic or hypomanic episode
  • Unstable dissociative symptoms
  • Recent hospitalization or severe instability
  • Active suicidal intent without a reliable safety plan

Assessment ensures ketamine is offered at an appropriate time and in a supportive therapeutic context.

Medication Considerations

Certain medications may affect safety or ketamine’s therapeutic impact. Screening includes review of:

  • Benzodiazepines (may reduce effectiveness)
  • Lamotrigine (may blunt dissociation)
  • MAOIs and some stimulants (require additional caution)
  • Other psychoactive medications that may interact with ketamine

Coordination with existing prescribers occurs when needed.

Clinical Monitoring, Safety, and Follow-Up

Ketamine sessions are conducted in a medical setting equipped for psychedelic-assisted care, where qualified healthcare professionals oversee evaluation, dosing, and continuous monitoring of vital signs, physical stability, and emotional wellbeing. Appropriate emergency protocols and medical equipment are maintained on-site. After each session, clients receive clear safety guidance—including avoiding driving or hazardous activities until the following day—must have arranged transportation home, and participate in scheduled integration sessions. Coordination with other healthcare providers is offered when helpful to support continuity, stability, and safety throughout the course of treatment.


 

What Makes Emergence Psychedelic Therapy Different

At Emergence Psychedelic Therapy, LLC, ketamine therapy is provided within a comprehensive, physician-led, trauma-informed model.

Our approach includes:

  • Thorough medical and psychiatric evaluation
  • Thoughtful preparation
  • Medically supervised ketamine administration
  • Structured therapeutic integration
  • Collaboration with existing care providers

This model honors both clinical safety and the human dimensions of healing.

A Path Toward Renewal

Depression, anxiety, and trauma can narrow a person’s world and make meaningful change feel out of reach. Ketamine therapy and ketamine-assisted therapy (KAP) can help open space—space for relief, clarity, and forward movement.

If you are researching ketamine therapy or ketamine-assisted therapy (KAP) in Boulder, Colorado, Emergence Psychedelic Therapy offers comprehensive, physician-led care with a focus on safety, preparation, and integration. You are welcome to reach out if you’d like to learn more or discuss whether ketamine-assisted therapy may be appropriate for you.

 

Further Reading (User-Friendly Resources)

These resources offer accessible, research-informed information about ketamine therapy, neuroplasticity, and emerging approaches to mental health care. They are written for a general audience interested in learning more.

Understanding Ketamine Therapy

Ketamine-Assisted Psychotherapy & Psychedelic Medicine

Neuroplasticity & Brain Health

PTSD, Depression, and Trauma-Informed Care

References

  1. Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: A randomized controlled trial. JAMA Psychiatry. 2013;70(10):1134-1142.
  2. Zolghadriha A, Chiu CN, Best J, et al. Rapid and sustained antidepressant effects of intravenous ketamine in major depressive disorder: A systematic review and meta-analysis. BMC Psychiatry. 2024;24:91.
  3. Anand A, Hammoud M, Karne H, et al. Ketamine versus electroconvulsive therapy for nonpsychotic treatment-resistant major depression. N Engl J Med. 2023;388:2313-2323.
  4. Feder A, Parides MK, Murrough JW, et al. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry. 2014;71(6):681-688.
  5. Feder A, Costi S, Rutter SB, et al. A randomized controlled trial of repeated ketamine infusions for chronic PTSD. Am J Psychiatry. 2021;178(2):193-202.
  6. Grunebaum MF, Ellis SP, Keilp JG, et al. Ketamine for rapid reduction of suicidal thoughts in major depression: A randomized clinical trial. Am J Psychiatry. 2018;175(4):327-335.
  7. Wilkinson ST, Ballard ED, Bloch MH, et al. The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data meta-analysis. Depress Anxiety. 2018;35(4):335-345.
  8. Diazgranados N, Ibrahim LA, Brutsche NE, et al. A randomized add-on trial of ketamine in bipolar depression. Biol Psychiatry. 2010;67(2):150-155.
  9. Glue P, Neehoff S, Sabadel A, et al. Effects of ketamine in generalized anxiety disorder and social anxiety disorder: A randomized, placebo-controlled trial. J Psychopharmacol. 2017;31(10):1305-1312.
  10. Autry AE, Adachi M, Nosyreva E, et al. NMDA receptor blockade induces rapid antidepressant actions via BDNF signaling pathways. Nature. 2011;475(7354):91-95.
  11. Duman RS, Aghajanian GK. Synaptic dysfunction in depression: Potential therapeutic targets. Science. 2012;338(6103):68-72.
  12. Drozdz SJ, Singh S, Ruan S, et al. Ketamine-assisted psychotherapy: A systematic narrative review. J Psychedelic Stud. 2022;6(1):1-15.
  13. U.S. Food and Drug Administration. Spravato (esketamine) nasal spray prescribing information. FDA; Revised 2025.

Interested in Learning More?

If you’re curious about psychedelic medicine and psilocybin-assisted therapy, you’re welcome to reach out to explore more.

We are happy to provide general information, answer questions about the therapeutic process, or help you understand what to expect as you explore whether this work aligns with your goals.

You can contact us anytime to learn more or continue the conversation.

The information in this blog is for educational purposes only and is not medical advice. Reading these articles does not establish a patient–provider relationship, and individual clinical recommendations can only be made within the context of a formal evaluation. It’s recommended that readers consult with their own medical and mental health providers before making any changes to their treatments, medications, medical and/or therapeutic approaches to their health care. Laws and regulations regarding psychedelic and natural medicines, vary by country, state, and local jurisdiction, and readers are responsible for understanding the policies that apply in their own area.